Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Rimsza

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
Archives of Pathology & Laboratory Medicine|December 8, 2006
Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survivalChadwick F Haarer, Robin A Roberts, Yvette M Frutiger, et al.
AIDS (London, England)|August 11, 2020
Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIVVolodymyr Shponka, Candace Y Reveles, Sinthia Alam, et al.
Leukemia & Lymphoma|April 25, 2007
HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimenLisa M Rimsza, Pedro Farinha, Deborah A Fuchs, et al.
Biology of the Neonate|September 30, 2005
Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonatesMatthew A Saxonhouse, Lisa M Rimsza, Gary Stevens, et al.
Neonatology|February 6, 2010
Differences between newborn and adult mice in their response to immune thrombocytopeniaZhongbo Hu, William B Slayton, Lisa M Rimsza, et al.
Blood Cancer Journal|May 18, 2019
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphomaGrzegorz S Nowakowski, Tatyana Feldman, Lisa M Rimsza, et al.
Blood|August 20, 2002
AML, angiogenesis, and prognostic variablesLisa M Rimsza, Kim P Ahrens, James K Massey, et al.
British Journal of Haematology|October 31, 2002
Developmental changes in the expression of transcription factors GATA-1, -2 and -3 during the onset of human medullary haematopoiesisChristof Dame, Martha C Sola, Joachim Fandrey, et al.
American Journal of Clinical Pathology|June 19, 2012
Developmental differences in megakaryocyte size in infants and childrenDeborah A Fuchs, Sarah G McGinn, Carlos L Cantu, et al.
Journal of Hematopathology|November 16, 2020
Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphomaColleen A Ramsower, Alanna Maguire, Ryan S Robetorye, et al.
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
Archives of Pathology & Laboratory Medicine|December 8, 2006
Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survivalChadwick F Haarer, Robin A Roberts, Yvette M Frutiger, et al.
AIDS (London, England)|August 11, 2020
Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIVVolodymyr Shponka, Candace Y Reveles, Sinthia Alam, et al.
Leukemia & Lymphoma|April 25, 2007
HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimenLisa M Rimsza, Pedro Farinha, Deborah A Fuchs, et al.
Biology of the Neonate|September 30, 2005
Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonatesMatthew A Saxonhouse, Lisa M Rimsza, Gary Stevens, et al.
Neonatology|February 6, 2010
Differences between newborn and adult mice in their response to immune thrombocytopeniaZhongbo Hu, William B Slayton, Lisa M Rimsza, et al.
Blood Cancer Journal|May 18, 2019
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphomaGrzegorz S Nowakowski, Tatyana Feldman, Lisa M Rimsza, et al.
Blood|August 20, 2002
AML, angiogenesis, and prognostic variablesLisa M Rimsza, Kim P Ahrens, James K Massey, et al.
British Journal of Haematology|October 31, 2002
Developmental changes in the expression of transcription factors GATA-1, -2 and -3 during the onset of human medullary haematopoiesisChristof Dame, Martha C Sola, Joachim Fandrey, et al.
American Journal of Clinical Pathology|June 19, 2012
Developmental differences in megakaryocyte size in infants and childrenDeborah A Fuchs, Sarah G McGinn, Carlos L Cantu, et al.
Journal of Hematopathology|November 16, 2020
Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphomaColleen A Ramsower, Alanna Maguire, Ryan S Robetorye, et al.
Pageof 17